Intravenous fluids (n = 37) | Intravenous medicines (n = 22) | Total articles (n = 50) | Comments | |||
---|---|---|---|---|---|---|
TPN (n = 10) | Saline, dextrose, other (n = 27)* | Water for Injection (n = 3) | Medicines (n = 19)** | |||
Country income level | ||||||
Low-income (LIC) | – | 7 | – | 2 | 4 | In total, reports originated from 17 countries, representing 2 LIC, 9 Lower-MIC and 6 Upper-MIC |
Lower middle-income (lower-MIC) | 2 | 12 | 2 | 6 | 25 | |
Upper middle-income (upper-MIC) | 9 | 5 | 1 | 8 | 21 | |
Patients–wards–duration of outbreak Median (range) duration: 8 weeks (1 day–156 weeks) (data: n = 43 articles) | ||||||
Adults (A) and/or children (C) affected | 1A/8C | 6A/22C | 1A/2C | 8A/7C | 16A/31C | Articles providing information about ward: n = 48 Articles providing information about duration: n = 45 Total number of patients affected: 1025 Total number of children affected: 761 Median (range) number of patients affected per outbreak: 12 [3] (3 - 185) Median (range) case fatality ratio: 21.1% (0.0–87.5%) (data: n = 33 articles) |
Neonatal Intensive care unit | 6 | 16 | 1 | 5 | 19 | |
Adult intensive care unit | – | 2 | – | 3 | 7 | |
Hematology/oncology | – | 2 | 1 | 2 | 4 | |
Other wards | 3 | 10 | 2 | 9 | 23 | |
Duration > 1 month | 5 | 17 | 3 | 11 | 27 | |
Duration > 3 months | 3 | 13 | 2 | 7 | 16 | |
Pathogens Gram-negative bacteria (n = 59 isolates) | ||||||
Enterobacterales (n = 29 isolates) | 8 | 15 | 0 | 6 | 26 | In 4 articles, more than 1 species was identified from the infusates [26, 35, 40, 66] Where appropriate, the original (superseded) names of the bacteria are included in the comments to reflect taxonomic changes. They include: Burkholderia cepacia—(Pseudomonas cepacia) [44] Saprochaete capitata—(Blastoschizomyces capitatus) [42] Pluralibacter gergoviae—(Enterobacter gergoviae) [54] Elizabethkingia meningoseptica—(Chryseobacterium meningosepticum) [46] Klebsiella aerogenes—(Enterobacter aerogenes) [61] Rhizobium radiobacter—(Agrobacterium tumefaciens) [66] |
Serratia sp. | 2 | 3 | – | 2 | 7 | |
Klebsiella sp. | 1 | 9 | – | 3 | 10 | |
Enterobacter sp. | 2 | 1 | – | 1 | 4 | |
Leclercia decarboxylata | 1 | – | – | – | 1 | |
Pantoea sp. | 1 | – | – | – | 1 | |
Phytobacter diazotrophicus | 1 | – | – | – | 1 | |
Pluralibacter gergoviae | – | 1 | – | – | 1 | |
Proteus mirabilis | – | 1 | – | – | 1 | |
NFGNB (n = 30 isolates) | 2 | 11 | 5 | 11 | 25 | |
Burkholderia cepacia complex | – | 7 | 2 | 7 | 12 | |
Ralstonia sp. | – | 1 | 2 | 1 | 4 | |
Acinetobacter baumannii | 2 | 1 | – | – | 3 | |
Achromobacter sp. | – | – | – | 1 | 1 | |
Elizabethkingia meningoseptica | – | 1 | – | – | 1 | |
Myroides odoratus | – | – | 1 | – | 1 | |
Pseudomonas sp. | – | 1 | – | 1 | 2 | |
Rhizobium radiobacter | – | – | – | 1 | 1 | |
Fungi (n = 3 isolates) | ||||||
Candida albicans | 1 | – | – | – | 1 | |
Saprochaete capitata | – | 1 | – | – | 1 | |
Sarocladium kiliense | – | – | – | 1 | 1 | |
Gram-positive bacteria (n = 1 isolate) | ||||||
Bacillus circulans | – | – | – | 1 | 1 | |
Contamination route | ||||||
Intrinsic contamination | 4 | 2 | 3 | 11 | 19 | Articles providing information about intrinsic contamination: n = 19 Articles providing information or hypothesis about extrinsic contamination: n = 30 |
Extrinsic contamination | 6 | 23 | – | 8 | 30 | |
Used as mSDV | – | 18 | – | 7 | 20 | |
Used as admixture | – | 6 | – | – | 5 | |
Unsafe or deficient IPC practices | 7 | 25 | – | 8 | 40 |